Abstract
Objective
In utero exposure to steroid hormones may be related to risk of some cancers such as testicular germ cell tumors (TGCT). To determine whether placental characteristics are good surrogate measures of maternal biomarker levels, we evaluated the correlations in mothers of sons at higher (whites, n = 150) and lower (blacks, n = 150) risk of TGCT. Associations with birth weight were also examined.
Methods
All mothers, participants in the Collaborative Perinatal Project, were primigravidas who gave birth to male singletons. Associations between placental weight and placental thickness and third-trimester biomarker levels were evaluated using linear regression. Partial correlation coefficients for placental characteristics and birth weight were also estimated.
Results
Placental weight was positively correlated with alpha-fetoprotein (AFP), sex hormone-binding globulin (SHBG), testosterone, estradiol and estriol in whites, and AFP and estriol in blacks. Placental thickness was not associated with any biomarker. After adjustment for placental weight, birth weight was not correlated with any biomarker.
Conclusions
In these data, placental weight was modestly correlated with third-trimester biomarker level; however, it appeared to be a better surrogate for third-trimester biomarker level than birth weight. Placental thickness had limited utility as a surrogate measure for biomarker levels.
Similar content being viewed by others
References
Barker DJ, Thornburg KL, Osmond C, Kajantie E, Eriksson JG (2010) The prenatal origins of lung cancer. II. The placenta. Am J Hum Biol 22(4):512–516
Trichopoulos D (1990) Hypothesis: does breast cancer originate in utero? Lancet 335(8695):939–940
Henderson BE, Benton B, Jing J, Yu MC, Pike MC (1979) Risk factors for cancer of the testis in young men. Int J Cancer 23(5):598–602
Moller H, Skakkebaek NE (1997) Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control 8(6):904–912
Cnattingius S, Eloranta S, Adami HO et al (2008) Placental weight and risk of invasive epithelial ovarian cancer with an early age of onset. Cancer Epidemiol Biomarkers Prev 17(9):2344–2349
Hardy MJ, Humeida AK, Bahijri SM, Basalamah AH (1981) Late third trimester unconjugated serum oestriol levels in normal and hypertensive pregnancy: relation to birth weight. Br J Obstet Gynaecol 88(10):976–982
McFadyen IR, Worth HG, Wright DJ, Notta SS (1982) High oestrogen excretion in pregnancy. Br J Obstet Gynaecol 89(12):994–999
Lechner W, Marth C, Daxenbichler G (1985) Correlation of oestriol levels in saliva, plasma and urine of pregnant women. Acta Endocrinol (Copenh) 109(2):266–268
Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE (1986) Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 76(6):1035–1039
Petridou E, Panagiotopoulou K, Katsouyanni K, Spanos E, Trichopoulos D (1990) Tobacco smoking, pregnancy estrogens, and birth weight. Epidemiology 1(3):247–250
Kaijser M, Granath F, Jacobsen G, Cnattingius S, Ekbom A (2000) Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. Epidemiology 11(3):315–319
Kaijser M, Jacobsen G, Granath F, Cnattingius S, Ekbom A (2002) Maternal age, anthropometrics and pregnancy oestriol. Paediatr Perinat Epidemiol 16(2):149–153
Mucci LA, Lagiou P, Tamimi RM, Hsieh CC, Adami HO, Trichopoulos D (2003) Pregnancy estriol, estradiol, progesterone and prolactin in relation to birth weight and other birth size variables (United States). Cancer Causes Control 14(4):311–318
Troisi R, Potischman N, Roberts J et al (2003) Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States). Cancer Causes Control 14(4):347–355
Nagata C, Iwasa S, Shiraki M, Shimizu H (2006) Estrogen and alpha-fetoprotein levels in maternal and umbilical cord blood samples in relation to birth weight. Cancer Epidemiol Biomarkers Prev 15(8):1469–1472
Larfors G, Lambert PC, Lambe M, Ekbom A, Cnattingius S (2009) Placental weight and breast cancer survival in young women. Cancer Epidemiol Biomarkers Prev 18(3):777–783
Murray RS (2006) Placental weight and maternal risk of breast cancer. JAMA 295(10):1124–1125
Cnattingius S, Torrang A, Ekbom A, Granath F, Petersson G, Lambe M (2005) Pregnancy characteristics and maternal risk of breast cancer. JAMA 294(19):2474–2480
Niswander KR, Gordon M (1972) The women and their pregnancies. WB Saunders, Philadelphia
Zhang Y, Graubard BI, Klebanoff MA et al (2005) Maternal hormone levels among populations at high and low risk of testicular germ cell cancer. Br J Cancer 92(9):1787–1793
Zhang Y, Graubard BI, Longnecker MP, Stanczyk FZ, Klebanoff MA, McGlynn KA (2007) Maternal hormone levels and perinatal characteristics: implications for testicular cancer. Ann Epidemiol 17(2):85–92
Benirschke K (1961) Examination of the placenta, prepared for the collaborative study on cerebral palsy, mental retardation and other neurological and sensory disorders of infancy and childhood. National institute of neurological diseases and blindness, US Department of Health, Education and Welfare, Public Health Service, Bethesda, MD
Salafia CM, Misra DP, Yampolsky M, Charles AK, Miller RK (2009) Allometric metabolic scaling and fetal and placental weight. Placenta 30(4):355–360
Goebelsmann U, Katagiri H, Stanczyk FZ, Cetrulo CL, Freeman RK (1975) Estriol assays in obstetrics. J Steroid Biochem 6(5):703–709
Katagiri H, Stanczyk FZ, Goebelsmann U (1974) Estriol in pregnancy. III. Development, comparison and use of specific antisera for rapid radioimmunoassay of unconjugated estriol in pregnancy plasma. Steroids 24(2):225–238
Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84(10):3666–3672
Depue RH, Pike MC, Henderson BE (1983) Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 71(6):1151–1155
Brown LM, Pottern LM, Hoover RN (1986) Prenatal and perinatal risk factors for testicular cancer. Cancer Res 46(9):4812–4816
Swerdlow AJ, Huttly SR, Smith PG (1987) Prenatal and familial associations of testicular cancer. Br J Cancer 55(5):571–577
Prener A, Hsieh CC, Engholm G, Trichopoulos D, Jensen OM (1992) Birth order and risk of testicular cancer. Cancer Causes Control 3(3):265–272
Akre O, Ekbom A, Hsieh CC, Trichopoulos D, Adami HO (1996) Testicular nonseminoma and seminoma in relation to perinatal characteristics. J Natl Cancer Inst 88(13):883–889
Sabroe S, Olsen J (1998) Perinatal correlates of specific histological types of testicular cancer in patients below 35 years of age: a case-cohort study based on midwives’ records in Denmark. Int J Cancer 78(2):140–143
Richiardi L, Akre O, Bellocco R, Ekbom A (2002) Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes. Br J Cancer 87(5):545–550
The Swedish Medical Birth Register: a summary of content and quality (2003) Stockholm, Sweden: Centre for Epidemiology, The National Board of Health and Welfare
Eriksson JG, Forsen T, Tuomilehto J, Osmond C, Barker DJ (2001) Early growth and coronary heart disease in later life: longitudinal study. BMJ 322(7292):949–953
Irgens LM (2000) The medical birth registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 79(6):435–439
Simmons D, France JT, Keelan JA, Song L, Knox BS (1994) Sex differences in umbilical cord serum levels of inhibin, testosterone, oestradiol, dehydroepiandrosterone sulphate, and sex hormone-binding globulin in human term neonates. Biol Neonate 65(5):287–294
Larsen SO, Wojdemann KR, Shalmi AC, Sundberg K, Christiansen M, Tabor A (2002) Gender impact on first trimester markers in down syndrome screening. Prenat Diagn 22(13):1207–1208
Hsing AW, Comstock GW, Polk BF (1989) Effect of repeated freezing and thawing on vitamins and hormones in serum. Clin Chem 35(10):2145
Lipworth L, Hsieh CC, Wide L et al (1999) Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer 79(1):7–12
Acknowledgments
Support for this research was provided by the Intramural Research Programs of the National Cancer Institute, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Environmental Health Sciences of the National Institutes of Health (NIH).
Conflict of interest
The authors declare no conflicts of interest of financial disclosures.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trabert, B., Longnecker, M.P., Graubard, B.I. et al. Placental characteristics as a proxy measure of serum hormone and protein levels during pregnancy with a male fetus. Cancer Causes Control 22, 689–695 (2011). https://doi.org/10.1007/s10552-011-9741-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-011-9741-8